Adding to Shorts
With S&P cash -9 handles I am adding to Index, ($GRNY) and ($JOET) shorts.
Positions: Short SPY M QQQ M GRNY M JOET S
Tech (XLK) Vs. Financials (XLF)
Chart from 9:37 a.m. ET.
Upside, Downside Premarket Movers
… a bit late, but still here:
Upside:
-BJDX +165% (partners with Argonaut Manufacturing Services to support Symphony platform)
-VSXY +32% (earnings, guidance)
-HPE +29% (earnings, guidance; appoints Christopher Hsu of Elliott Investment Management to Board of Directors)
-MRVL +18% (Nvidia’s CEO says Marvell could be next to join $1T market cap club)
-CTRN +15% (earnings, guidance)
-CAMT +11% (receives $55M multi-system order and $50M+ Hawk system orders for 2027 delivery)
-GNRC +10% (signs global supply agreement with leading hyperscale data center operator to provide backup generators)
-STM +9.9% (raises data center revenue ambition; now about $1B in 2026 (prior nicely above $500M), could double in 2027 (prior well above $1B))
-MCHP +8.9% (Data center solutions unit revenue expected to grow 65% in 2026 to about $500M; Announces price increases)
-SIG +5.8% (earnings, guidance)
-DG +5.5% (earnings, guidance)
-SMCI +4.1% (showcases next gen AMD Helios rack-scale platform at Computex)
-TRIP +2.2% (Wedbush, Inc. Assumed TRIP with Outperform, price target: $19)
Downside:
-HKIT -62% (raises $8M in registered direct offering of 4.0M shares at $2.00/shr)
-FULC -51% (discontinues pociredir for sickle cell disease; explores strategic alternatives)
-ABVX -36% (reports Phase 3 ABTECT maintenance trial data in ulcerative colitis)
-CELC -24% (reports detailed efficacy and safety results in PIK3CA MT cohort for Phase 3 VIKTORIA-1 gedatolisib regimens vs alpelisib plus fulvestrant)
-ODD -23% (earnings, guidance)
-XMTR -9.8% (prices previously announced $225M sale of 2.65M shares at $85/share)
-LPTH -9.4% (prices registered direct primary and secondary offering of Class A common stock; 7,142,800 shares at $14.00/share)
-NU -7.1% (appoints Rob Livingston CFO)
-SHAK -6.8% (cuts guidance)
-INTU -6.4% (Goldman Sachs Cuts INTU to Sell from Neutral, price target: $276 from $519)
-SNOW -3.6% (profit taking)
-CRDO -3.3% (earnings, guidance)
-GOOGL -2.8% (authorizes proposed $80B equity capital raise to expand AI infrastructure and compute)
Positions: None.
Subscriber Question (And My Response)
Jaw4860
15m ago
Doug ,You quote Marcus and others ,What are their track records ?
DDougie Kass
just now
they are research analysts not running portfolios
i believe, unlike some, that my job is to provide contrarian views/analysis – ergo gary marcus tweets/columns
others feel differently
bullish views dominate the markets (wall street, fin tv ,etc.), thoughtful outside of consensus, provides food for thought for investors and traders considering sectors and weighting those sectors
warren buffett has done poorly in the last 5-10 years vs the markets – so should i stop quoting him?
druckenmiller, the goat, is on a bad streak – should we stop listening to him?
lee is having a rough year – are his views worthwhile?
considering pros and cons, creating a ledger on ideas is reasonable
if we confided the dialogue and discourse to those who are right… well, that is sub optimal
No Bull (on AI) – George Noble
Positions: None.
Treasury Auctions, Fed Speakers, Economic Calendar
11:00 a.m.: Treasury Announces a 4, 8 and 17 Week Bill Auction;
11:00 a.m.: Treasury buyback announcement (liq support); 1
1:30 a.m.: Treasury hosts a $75B 6-Week Bill Auction
Fed Speakers:
8:30 a.m.: Fed Bank of Cleveland President Hammack (Voter) gives remarks and participates in conversation on monetary policy co-hosted by the Cleveland Fed, the City Club of Cleveland, the Greater Cleveland Partnership, and the 50 Club of Cleveland, Cleveland, OH
Economic Calendar:
Positions: None.
ETF Action in the A.M.
Positions: None.
Charting the Morning Percent Movers
Positions: None.
Tweet of the Day (Part Four)
Position: None
El Capitan
Position: None